LGR4 promotes tumorigenesis by activating TGF-β1/Smad signaling pathway in multiple myeloma

Zhigang Yi; Tao Ma; Jia Liu; Wenting Tie; Yanhong Li; Jun Bai; Lijuan Li; Liansheng Zhang

doi:10.1016/j.cellsig.2023.110814

ScienceGate Book Chapters

JOURNAL ARTICLE

LGR4 promotes tumorigenesis by activating TGF-β1/Smad signaling pathway in multiple myeloma

Zhigang Yi Tao Ma Jia Liu Wenting Tie Yanhong Li Jun Bai Lijuan Li Liansheng Zhang

Year: 2023 Journal: Cellular Signalling Vol: 110 Pages: 110814-110814 Publisher: Elsevier BV

DOI: 10.1016/j.cellsig.2023.110814

Get Full-Text PDF Get Analytical Report

Keywords:

SMAD Downregulation and upregulation Cancer research Gene knockdown Multiple myeloma Carcinogenesis Signal transduction Transforming growth factor In vivo Apoptosis Cell biology Biology Internal medicine Chemistry Medicine Cancer Biochemistry Genetics Gene

Metrics

Cited By

2.34

FWCI (Field Weighted Citation Impact)

Refs

0.87

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Multiple Myeloma Research and Treatments

Health Sciences → Medicine → Hematology

Chemokine receptors and signaling

Health Sciences → Medicine → Oncology

Medicinal Plant Pharmacodynamics Research

Life Sciences → Pharmacology, Toxicology and Pharmaceutics → Pharmacology

LGR4 promotes tumorigenesis by activating TGF-β1/Smad signaling pathway in multiple myeloma

Metrics

Citation History

Topics

Related Documents

CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.

CD151 promotes cell metastasis via activating TGF-β1/Smad signaling in renal cell carcinoma

Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway

KIAA1429 Promotes Keloid Formation Through the TGF-Β1/Smad Pathway

miR‐522 stimulates TGF‐β/Smad signaling pathway and promotes osteosarcoma tumorigenesis by targeting PPM1A